Porsolt is an internationally recognized and long established global preclinical Contract Research Organization (CRO) long, that has been providing efficacy evaluation and safety pharmacology services for over 35 years.  Porsolt’s capabilities and services cover the drug development process from early screening through regulatory submission, including comprehensive safety evaluation of drug candidates in full compliance with GLP.

Porsolt was first audited for GLP Compliance in the year 2000, and has continuously maintained this status, with continued successful bi-annual inspections by the independent ANSM authority. Porsolt is also an AAALAC Accredited facility.

The quality of our work can be traced to the expert qualifications of our staff, with more than 150 years of combined scientific experience. This, together with over 35 years of institutional memory, provides a valuable source of advice and guidance for our clients with their development programs.

Porsolt’s clients include major Pharmaceutical Companies, Biotechnology Companies, Foundations, Not-For-Profits and Academic Institutions, from all around the world, with hundreds of studies being performed annually.

We aim to be an extension of our client’s team, effectively supporting R&D programs with validated and innovative solutions. We combine our core values of personalized customer service, flexibility, and scientific innovation, to provide a consistently superior service.